Yehuda Handelsman

21.7k total citations · 10 hit papers
113 papers, 9.3k citations indexed

About

Yehuda Handelsman is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Yehuda Handelsman has authored 113 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Endocrinology, Diabetes and Metabolism, 36 papers in Surgery and 22 papers in Molecular Biology. Recurrent topics in Yehuda Handelsman's work include Diabetes Treatment and Management (58 papers), Diabetes Management and Research (56 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers). Yehuda Handelsman is often cited by papers focused on Diabetes Treatment and Management (58 papers), Diabetes Management and Research (56 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers). Yehuda Handelsman collaborates with scholars based in United States, Australia and Canada. Yehuda Handelsman's co-authors include George Grunberger, Paul S. Jellinger, Alan J. Garber, Zachary T. Bloomgarden, Daniel Einhorn, Vivian Fonseca, Jeffrey I. Mechanick, Helena W. Rodbard, Paul D. Rosenblit and Michael A. Bush and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Yehuda Handelsman

108 papers receiving 8.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease

2017 775 citations Paul S. Jellinger, Yehuda Handelsman et al. Endocrine Practice profile →
Statement by an American Association of Clinical Endocrinologists/ American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control

2009 751 citations Helena W. Rodbard, Paul S. Jellinger et al. Endocrine Practice profile →
Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis

2016 505 citations George L. Bakris, Yehuda Handelsman et al. profile →
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

2020 411 citations Alan J. Garber, Yehuda Handelsman et al. Endocrine Practice profile →
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis

2012 407 citations Paul S. Jellinger, Donald A. Smith et al. Endocrine Practice profile →
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial

2017 400 citations Yehuda Handelsman et al. profile →
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary

2018 377 citations Alan J. Garber, Martin J. Abrahamson et al. Endocrine Practice profile →
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm – 2017 Executive Summary

2017 327 citations Alan J. Garber, Martin J. Abrahamson et al. Endocrine Practice profile →
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2019 Executive Summary

2019 225 citations Alan J. Garber, Martin J. Abrahamson et al. Endocrine Practice profile →
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus

2021 179 citations George Grunberger, Jennifer L. Sherr et al. Endocrine Practice profile →

Peers

Countries citing papers authored by Yehuda Handelsman

Since Specialization

Citations

This map shows the geographic impact of Yehuda Handelsman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yehuda Handelsman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yehuda Handelsman more than expected).

Fields of papers citing papers by Yehuda Handelsman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yehuda Handelsman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yehuda Handelsman. The network helps show where Yehuda Handelsman may publish in the future.

Co-authorship network of co-authors of Yehuda Handelsman

This figure shows the co-authorship network connecting the top 25 collaborators of Yehuda Handelsman. A scholar is included among the top collaborators of Yehuda Handelsman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yehuda Handelsman. Yehuda Handelsman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Study protocol for a prospective, multicentre study of hypercortisolism in patients with difficult-to-control type 2 diabetes (CATALYST): prevalence and treatment with mifepristone 2024 ·BMJ Open ·Ralph A. DeFronzo, Richard J. Auchus, Irina Bancos, Lawrence Blonde, Robert S. Busch, John B. Buse, James W. Findling, Vivian Fonseca, Juan P. Frías, Oksana Hamidi, Yehuda Handelsman, Richard E. Pratley, Julio Rosenstock, Iulia Cristina Tudor, Andreas Moraitis, Daniel Einhorn	0
2	Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases 2023 ·Journal of Diabetes and its Complications ·Yehuda Handelsman, Javed Butler, George L. Bakris, Ralph A. DeFronzo, Gregg C. Fonarow, Jennifer B. Green, George Grunberger, James L. Januzzi, Samuel Klein, Pamela Kushner, Darren K. McGuire, Erin D. Michos, Javier Morales, Richard E. Pratley, Matthew R. Weir, Eugene E. Wright, Vivian Fonseca	43
3	Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS/ADONIS studies 2022 ·Journal of Diabetes and its Complications ·Yehuda Handelsman, T. Jared Bunch, Helena W. Rodbard, Benjamin A. Steinberg, (unknown), (unknown), (unknown), Mattias Wieloch, Peter R. Kowey	4
4	American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus breakdown → 2021 ·Endocrine Practice ·George Grunberger, Jennifer L. Sherr, (unknown), Thomas Blevins, Bruce W. Bode, Yehuda Handelsman, Richard Hellman, Rosemarie Lajara, V. Roberts, David Rodbard, (unknown), Jeff Unger	179
5	Use of Sodium–Glucose Co-Transporter-2 Inhibitors in Patients with and without Type 2 Diabetes: Implications for Incident and Prevalent Heart Failure 2020 ·European Journal of Heart Failure ·Javed Butler, Yehuda Handelsman, George L. Bakris, Subodh Verma	32
6	Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive Summary 2020 ·Endocrine Practice ·Yehuda Handelsman, Paul S. Jellinger, Chris Guerin, Zachary T. Bloomgarden, Eliot A. Brinton, Matthew J. Budoff, Michael H. Davidson, Daniel Einhorn, Sergio Fazio, Vivian Fonseca, Alan J. Garber, George Grunberger, Ronald M. Krauss, Jeffrey I. Mechanick, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne	150
7	Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine 2019 ·Advances in Therapy ·Yehuda Handelsman, Marcel H.A. Muskiet, Graydon S. Meneilly	6
8	<p>Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions of Control (POC-US) study</p> 2019 ·Patient Preference and Adherence ·Kenneth J. Tomaszewski, (unknown), Michelle Mocarski, (unknown), Davida Kruger, Yehuda Handelsman, (unknown), Meryl Brod	3
9	Long-term efficacy of evolocumab in reducing lipids in EU subjects with and without type 2 diabetes: an analysis from the open-label extension OSLER studies 2016 ·Diabetologia ·N Sattar, Paul Valensi, David Preiss, Robert Dent, Ian Bridges, Andrea Ruzza, Marcoli Cyrille, Yehuda Handelsman	1
10	AACE/ACE Comprehensive Diabetes Management Algorithm 2015 2015 ·Endocrine Practice ·Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Michael Davidson, Daniel Einhorn, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez, Michael Davidson	179
11	The Role of Bromocriptine-Qr in the Management of Type 2 Diabetes Expert Panel Recommendations 2013 ·Endocrine Practice ·Alan J. Garber, Lawrence Blonde, Zachary T. Bloomgarden, Yehuda Handelsman, Samuel Dagogo‐Jack	23
12	Diabetes and Cancer—An AACE/ACE Consensus Statement 2013 ·Endocrine Practice ·Yehuda Handelsman, Derek LeRoith, Zachary T. Bloomgarden, Samuel Dagogo‐Jack, Daniel Einhorn, Alan J. Garber, George Grunberger, R. Mack Harrell, Robert F. Gagel, Harold E. Lebovitz, Janet B. McGill, Charles H. Hennekens	67
13	American Association of Clinical Endocrinologists’ Position Statement on Clinical Nutrition and Health Promotion in Endocrinology Primary Writers Reviewers 2012 ·Endocrine Practice ·M. Molly McMahon, Daniel L. Hurley, Jeffrey I. Mechanick, Yehuda Handelsman, Elise M. Brett, (unknown), (unknown), J. Michael González-Campoy, (unknown), Osama Hamdy, (unknown), George E. Shambaugh, Vin Tangpricha, John A. Tayek, (unknown), Dace Trence, Daniel Weiss	5
14	Reduced nocturnal hypoglycaemia with insulin degludec as compared to insulin glargine: results of a 2-year randomised trial in type 2 diabetes 2012 ·Diabetologia ·Helena W. Rodbard, Bernard Zinman, Bertrand Cariou, Athena Philis‐Tsimikas, Yehuda Handelsman, Trine Vang Skjøth, (unknown), Chantal Mathieu	2
15	Initial Combination Therapy with Metformin plus Colesevelam in Drug-Naïve Hispanic Patients with Early Type 2 Diabetes 2012 ·Postgraduate Medicine ·Julio Rosenstock, (unknown), Yehuda Handelsman, Soamnauth Misir, Michael R. Jones, Sukumar Nagendran	6
16	Bile Acid Sequestrants for Lipid and Glucose Control 2010 ·Current Diabetes Reports ·Bart Staels, Yehuda Handelsman, Vivian Fonseca	65
17	Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US* 2010 ·Journal of Diabetes ·Earl S. Ford, Catherine C. Cowie, Chaoyang Li, Yehuda Handelsman, Zachary T. Bloomgarden	118
18	Gut hormones and the brain* 2009 ·Journal of Diabetes ·Yifei Zhang, Guang Ning, Yehuda Handelsman, Zachary T. Bloomgarden	4
19	Hypoglycemia in the intensive care unit 2007 ·Current Opinion in Clinical Nutrition & Metabolic Care ·Jeffrey I. Mechanick, Yehuda Handelsman, Zachary T. Bloomgarden	33
20	American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome 2005 ·Endocrine Practice ·Rhoda H. Cobin, Walter Futterweit, John E. Nestler, Gerald M. Reaven, Paul S. Jellinger, Yehuda Handelsman, Geoffrey P. Redmond, Samuel S. Thatcher	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact